A 5534New Jersey
Revises telehealth and telemedicine requirements concerning adult prescription of certain Schedule II drugs for treatment of attention-deficit/hyperactivity disorder.
In committee
Sep 24, 2026: Introduced, Referred to Assembly Health Committee